Navigation Links
Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis
Date:12/19/2011

p>].

The majority of patients suffering from a venous blood clot will experience a DVT alone. However, DVT can progress to become a potentially fatal PE if the blood clot breaks apart and travels to the lungs, ultimately blocking a blood vessel there. Even in the absence of a PE, DVT alone can have devastating and costly consequences such as post-thrombotic syndrome and an increased risk of recurring blood clots, and thus the achievement of treatment goals is critically important. The current treatment standard for DVT is the dual- drug approach of low molecular weight heparin administered by subcutaneous injection, with a VKA.

About Xarelto® (Rivaroxaban)

Rivaroxaban is an oral anticoagulant that was discovered in Bayer HealthCare's Pharmaceuticals' Wuppertal laboratories in Germany, and is being jointly developed by Bayer HealthCare Pharmaceuticals and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. It has a rapid onset of action with a predictable dose response and high bioavailability, no requirement for routine coagulation monitoring, as well as a limited potential for food and drug interactions. Like other similar medicines (antithrombotic agents), rivaroxaban may cause bleeding which may potentially be life threatening.

Rivaroxaban is marketed under the brand name Xarelto® for VTE prevention in adult patients following elective hip or knee replacement surgery. Rivaroxaban is approved in more than 110 countries worldwide and to date has been successfully launched in more than 85 countries by Bayer HealthCare Pharmaceuticals in this indication. In the U.S., where rivaroxaban has been successfully launched in July 2011, Janssen Pharmaceuticals, Inc. (a Johnson & Johnson Company) holds marketing rights for rivaroxaban. The Bayer HealthCare Pharmaceuticals sales force is supporting the Janssen Pharmaceuticals, Inc. in designated hospital accounts.

The ROCKET AF study compared once daily
'/>"/>

SOURCE Bayer UK
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery
2. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
3. Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
4. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
5. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
6. Fora Care Group Becomes Pioneering Educational Member of the International Society of Vascular Health
7. US Oncology Foundation Becomes Life Beyond Cancer Foundation
8. Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals
9. Triage Wireless, Inc. Becomes Sotera Wireless, Inc.
10. Brookstone Pharmaceuticals, LLC becomes Acella Pharmaceuticals, LLC
11. CVS Caremarks MinuteClinic Becomes First Retail Clinic Provider to Achieve Consecutive Accreditation Awards From The Joint Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 ... Society of Clinical Oncology    PharmaMar comunica ... SAR3007, resi noti dal dipartimento Ricerca e sviluppo ... miglioramento della sopravvivenza libera da progressione (PFS) dopo il ... con dacarbazina in pazienti con liposarcoma (LPS) o leiomiosarcoma ...
(Date:6/1/2015)... June 2, 2015 Amgen (NASDAQ: ... on a Phase 1b study to evaluate the ... oncolytic immunotherapy, in combination with Roche,s investigational anti-PDL1 ... with triple-negative breast cancer and colorectal cancer with ... investigational oncolytic immunotherapy designed to selectively replicate in ...
(Date:6/1/2015)... 1, 2015 Research ... the addition of the "Analysis of ... report to their offering.      ... in-depth analysis of the US Medical Image ... market dynamics, and trends across the US ...
Breaking Medicine Technology:PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 2Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 3Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 4Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 5Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 7Analysis of the US Medical Image Displays Market 2015-2017 2
(Date:6/2/2015)... 2015 Thermi, formerly ThermiAesthetics, a ... successfully transitioned into its new company headquarters in ... company’s continued rapid worldwide expansion and houses the ... 25 Thermi employees, including those of the warehousing, ... “As one of the fastest growing aesthetic companies ...
(Date:6/2/2015)... June 02, 2015 Atlantic Spine ... spine surgery with three locations in New Jersey, announces ... City. The new facility is at 1045 Park Avenue ... consultations and appointments can be arranged by calling 1-844-912-2406. ... at Atlantic Spine Center, has been a pioneer in ...
(Date:6/2/2015)... Vancouver, B.C., Canada (PRWEB) June 02, 2015 ... publisher of audit, compliance and risk solutions ... a new online risk management effectiveness gap-improvement program. ... the effect of uncertainty on objectives. Organizations not ... they improve their capabilities to do this (risk ...
(Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into its VIP Woman ... prestigious distinction for leadership in life coaching. NAPW is ... boasting more than 700,000 members and over 200 operating ... with this distinction,” said NAPW President Star Jones. “Her ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Everette-Gaines as a 2015-2016 inductee into its VIP ... with this prestigious distinction for leadership in business. ... for professional women, boasting more than 700,000 members ... pleased to welcome Kathy into this exceptional group ...
Breaking Medicine News(10 mins):Health News:Thermi Moves to New Corporate Headquarters as Rapid Company Expansion Continues 2Health News:Renowned Endoscopic Spine Surgeon Dr. Kaixuan Liu Announces Opening of Park Avenue Office 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4Health News:National Association of Professional Women Inducts Marcy Herrmann, Therapist, Life Coach, Advanced Handwriting Analyst, Into its VIP Professional Woman of the Year Circle 2Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2
... MIAMI, May 23 MDWebLive.com, offering live video,medical consultations ... has been launched in Miami by AmeriGroup,Holdings, Inc., ... their,doctors from home, office, hotel or anywhere else in ... for use with non-urgent healthcare related matters such as ...
... Amy Philo*, SAN DIEGO, May 23 ... May 10, 1998, Sharon Alley stabbed her eight,month ... Months before, Alley,was prescribed Paxil, became psychotic, and ... skull., Postpartum Support International (PSI) founder Jane ...
... and Health Care ... Service Offerings, BETHESDA, ... of Atlanta, Georgia based Eagle Group,International, LLC. Eagle Group provides logistics, ... Founded in 1995, Eagle Group employs more than 1,350 people. ...
... at Panther Expedited Services, Inc. selects the ... Prevent Cancer Foundation as Beneficiary, ALEXANDRIA, Va., ... chosen by Panther Expedited Services, Inc. as a,recipient of their ... Panther, a leader in premium air and ground transportation,headquartered in ...
... Anti-reflux procedure improved quality of life, cut need ... News) -- High levels of patient satisfaction and ... with gastroesophageal reflux disease (GERD) who had minimally ... experienced surgeon, says a U.S. study. , ...
... 21, 2008 A recent study shows that pre-operative assessments ... for early diagnosis and successful treatment of lymphedema. , ... (NNMC) and the National Institutes of Health (NIH) and ... Mason University, was published in the journal, Cancer (April ...
Cached Medicine News:Health News:Real Time, Face-to-Face Doctor Visits Now Available Online 2Health News:The MOTHERS Act: Thalidomide Revisited? 2Health News:The MOTHERS Act: Thalidomide Revisited? 3Health News:The MOTHERS Act: Thalidomide Revisited? 4Health News:Lockheed Martin Completes Acquisition of Eagle Group International, LLC 2Health News:New Supporters Join the Prevent Cancer Foundation Mission 2Health News:Patients Pleased With Laparoscopic GERD Surgery 2Health News:New study shows positive role physical therapists play in lymphedema diagnois and treatment 2
... Lobob hard contact lens cleaning ... to use, and professionally proven ... non-ionic detergents resulting in a ... protein deposits, cosmetic residue, salts, ...
Optimum C/D/S Solution is a sterile cleaning, disinfecting, and storage solution for use with fluorosilicone acrylate and silicone acrylate rigid gas permeable (RGP) and hard contact lenses....
Round knurled handle. Overall length 130 mm....
5 inch (12.7 cm), 2 x 5 mm blade....
Medicine Products: